Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive Disorder
CROVCD
Cognitive Rehabilitation of OIF/OEF Veterans With Cognitive Disorder
2 other identifiers
interventional
128
1 country
4
Brief Summary
The number of OEF/OIF veterans seeking care and rehabilitation services within the VA Health Care System is increasing rapidly. The cognitive effects of MTBI are clinically significant and can adversely affect a veteran's ability to reintegrate into civilian life, return to duty, succeed in competitive employment, or function independently. The primary product of the proposed study would be an empirically validated, manualized, cognitive rehabilitation intervention for OIF/OIF veterans with cognitive disorders. The group treatment modality has the virtue of efficiency and a manualized treatment approach would allow wide-ranging application throughout the VHA system. As such, the proposed study is likely to have a significant effect on the quality and effectiveness of rehabilitative services being offered to our returning soldiers with combat-related MTBI and cognitive impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2011
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2009
CompletedFirst Posted
Study publicly available on registry
December 30, 2009
CompletedStudy Start
First participant enrolled
May 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedResults Posted
Study results publicly available
January 26, 2015
CompletedJanuary 26, 2015
January 1, 2015
2 years
December 28, 2009
November 7, 2014
January 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Multiple Sclerosis Neuropsychological Screening Questionnaire-Patient Version
A self-report measure of severity of attention and organizational problems. It measures the sum of severity ratings on a scale from 0 (never) to 4 (very often). The total score ranges from 0 to 64.
Week 10
Secondary Outcomes (11)
Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford, Henry, Ward, &
Week 10
The Neurobehavioral Symptom Inventory
Week 10
Memory Compensation Questionnaire
Week 10
Hopkins Verbal Memory Test-Revised
Week 10
Wechsler Adult Intelligence Scale-3rd Edition, Digit Span Subtest
Week 10
- +6 more secondary outcomes
Study Arms (2)
Cognitive Strategies Training
EXPERIMENTALParticipants in the experimental group will receive the Cognitive strategy intervention during the first ten weeks of their participation in the study, whereas comparison group participants will continue to receive usual care (no cognitive strategy intervention) during their participation in the study (but will be offered cognitive strategy intervention after the end of the study). Cognitive Strategies training consisted of interactive didactic presentations, in-class discussions, and activities that introduced participants to a variety of cognitive strategies and external aids.
Placebo comparison group
PLACEBO COMPARATORParticipants in the experimental group will receive the Cognitive strategy intervention during the first ten weeks of their participation in the study, whereas comparison group participants will continue to receive usual care (no cognitive strategy intervention) during their participation in the study (but will be offered cognitive strategy intervention after the end of the study).
Interventions
Cognitive Strategy Training will consist of weekly 120-minute group sessions for 10 weeks.
Participants in the experimental group will receive the Cognitive strategy intervention during the first ten weeks of their participation in the study, whereas comparison group participants will continue to receive usual care (no cognitive strategy intervention) during their participation in the study (but will be offered cognitive strategy intervention after the end of the study).
Eligibility Criteria
You may qualify if:
- OEF/OIF veterans enrolled at a participating VA who are able to provide informed consent; and
- As part of standard VA clinical care, have screened positive for MTBI and complain of cognitive impairment.
You may not qualify if:
- Current substance use disorder with less than 30 days abstinence;
- History of a primary psychotic disorder; and
- Auditory or visual impairments that would prevent ability to participate in the cognitive rehabilitation group or benefit from compensatory strategies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
VA San Diego Healthcare System, San Diego
San Diego, California, 92161, United States
VA Medical Center, Boise
Boise, Idaho, 83702, United States
VA Medical Center, Portland
Portland, Oregon, 97201, United States
VA Puget Sound Health Care System, Seattle
Seattle, Washington, 98108, United States
Related Publications (1)
Pagulayan KF, O'Neil M, Williams RM, Turner AP, Golshan S, Roost MS, Laman-Maharg B, Huckans M, Storzbach D, Twamley EW. Mental Health Does Not Moderate Compensatory Cognitive Training Efficacy for Veterans With a History of Mild Traumatic Brain Injury. Arch Phys Med Rehabil. 2017 Sep;98(9):1893-1896.e2. doi: 10.1016/j.apmr.2017.04.009. Epub 2017 May 5.
PMID: 28483653DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Daniel Storzbach
- Organization
- Portland VA Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel M Storzbach, PhD
VA Medical Center, Portland
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2009
First Posted
December 30, 2009
Study Start
May 1, 2011
Primary Completion
May 1, 2013
Study Completion
September 1, 2013
Last Updated
January 26, 2015
Results First Posted
January 26, 2015
Record last verified: 2015-01